Income Statement Summit Therapeutics Inc.

Equities

SMMT

US86627T1088

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 15:09:30 16/03/2026 GMT			5-day change	1st Jan Change
16.10 ^USD	-0.16%		+1.02%	-9.21%

03-11	Summit Therapeutics Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 02:15 PM
03-02	Summit Therapeutics Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 02:30 PM

f73.wgwLw6rT_v2AYck58CsJhAhs_Lcc193vHZMES2bez5c.u19GscOHrJvNJ4RKmEdt_GQDze13sqyIcNtbOTHziviEZFyUwOexsswFgA

Published financial data: SUMMIT THERAPEUTICS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	1.81M	705K	-	-	-
Other Revenues, Total	-	-	-	-	-
Total Revenues	1.81M	705K	-	-	-
Gross Profit	1.81M	705K	-	-	-
Selling General & Admin Expenses, Total	23.61M	26.74M	30.26M	60.53M	557M
R&D Expenses	85.35M	53.26M	59.47M	151M	538M
Other Operating Expenses	-20.97M	-14.42M	-1M	-313K	-
Other Operating Expenses, Total	88M	65.59M	88.74M	211M	1.09B
Operating Income	-86.19M	-64.89M	-88.74M	-211M	-1.09B
Interest Expense, Total	-281K	-4.4M	-16.46M	-8.69M	-
Interest And Investment Income	-	1.51M	10.4M	13.47M	15.5M
Net Interest Expenses	-281K	-2.89M	-6.06M	4.78M	15.5M
Currency Exchange Gains (Loss)	-2.14M	-4.11M	1.03M	-97K	-610K
Other Non Operating Income (Expenses)	-	304K	-252K	-	-53K
EBT, Excl. Unusual Items	-88.6M	-71.58M	-94.01M	-206M	-1.08B
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Asset Writedown	-	-8.47M	-	-	-
In Process R&D Expenses	-	-	-521M	-15.01M	-
Other Unusual Items	-	1.26M	-	-	-
EBT, Incl. Unusual Items	-88.6M	-78.78M	-615M	-221M	-1.08B
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-88.6M	-78.78M	-615M	-221M	-1.08B
Net Income to Company	-88.6M	-78.78M	-615M	-221M	-1.08B
Net Income - (IS)	-88.6M	-78.78M	-615M	-221M	-1.08B
Net Income to Common Incl Extra Items	-88.6M	-78.78M	-615M	-221M	-1.08B
Net Income to Common Excl. Extra Items	-88.6M	-78.78M	-615M	-221M	-1.08B
Per Share Items
Net EPS - Basic	-0.96	-0.41	-0.99	-0.31	-1.44
Basic EPS - Continuing Operations	-0.96	-0.41	-0.99	-0.31	-1.44
Basic Weighted Average Shares Outstanding	92.24M	193M	620M	719M	748M
Net EPS - Diluted	-0.96	-0.41	-0.99	-0.31	-1.44
Diluted EPS - Continuing Operations	-0.96	-0.41	-0.99	-0.31	-1.44
Diluted Weighted Average Shares Outstanding	92.24M	193M	620M	719M	748M
Normalized Basic EPS	-0.6	-0.23	-0.09	-0.18	-0.9
Normalized Diluted EPS	-0.6	-0.23	-0.09	-0.18	-0.9
American Depositary Receipts Ratio (ADR)	5	5	5	5	5
Supplemental Items
EBITDA	-84.84M	-63.62M	-88.54M	-211M	-1.09B
EBITA	-85.17M	-63.97M	-88.74M	-211M	-1.09B
EBIT	-86.19M	-64.89M	-88.74M	-211M	-1.09B
EBITDAR	-83.61M	-62.07M	-86.24M	-207M	-1.09B
Effective Tax Rate - (Ratio)	-	-	-	-	-
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-55.38M	-44.74M	-58.76M	-129M	-675M
Interest on Long-Term Debt	-	-	16.46M	8.7M	-
Supplemental Operating Expense Items
General and Administrative Expenses	23.61M	26.74M	30.26M	60.53M	557M
Research And Development Expense From Footnotes	85.35M	52M	580M	166M	538M
Net Rental Expense, Total	1.23M	1.55M	2.3M	3.51M	4.08M
Imputed Operating Lease Interest Expense	1.7M	210K	968K	4.3M	-
Imputed Operating Lease Depreciation	-472K	1.34M	1.33M	-795K	-
Stock-Based Comp., R&D Exp. (Total)	5.91M	4.3M	4.41M	16.01M	219M
Stock-Based Comp., G&A Exp. (Total)	6.9M	7.64M	9.7M	34.97M	514M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	12.8M	11.95M	14.11M	50.98M	732M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	71.79M	349M	71.42M	105M	225M
Short Term Investments	-	-	115M	307M	488M
Total Cash And Short Term Investments	71.79M	349M	186M	412M	713M
Accounts Receivable, Total	2.04M	349K	-	-	-
Other Receivables	15.7M	5.77M	848K	557K	-
Total Receivables	17.73M	6.12M	848K	557K	-
Prepaid Expenses	7.16M	1.5M	2.44M	10.52M	6.54M
Restricted Cash	-	300M	-	325K	316K
Other Current Assets, Total	627K	486K	181K	-	-
Total Current Assets	97.31M	657M	190M	424M	720M
Gross Property Plant And Equipment	6.86M	6.38M	7.1M	8.52M	-
Accumulated Depreciation	-3.38M	-1.3M	-1.04M	-1.12M	-
Net Property Plant And Equipment	3.48M	5.08M	6.06M	7.4M	21.68M
Goodwill	2.01M	1.8M	1.89M	1.86M	2M
Other Intangibles, Total	10.4M	-	-	-	-
Other Long-Term Assets, Total	170K	577K	5.28M	2.55M	7.2M
Total Assets	113M	664M	203M	436M	751M
Liabilities
Accounts Payable, Total	4.37M	355K	2.67M	4.64M	20.29M
Accrued Expenses, Total	11.32M	16.3M	14.21M	31.53M	47.02M
Current Portion of Long-Term Debt	-	19.77M	-	-	-
Current Portion of Leases	1.09M	1.69M	2.81M	3.76M	3.39M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	7.94M	-	-	-	-
Other Current Liabilities	897K	662K	717K	1.8M	2.28M
Total Current Liabilities	25.62M	38.78M	20.4M	41.73M	72.99M
Long-Term Debt	-	495M	100M	-	-
Long-Term Leases	1.69M	2.76M	3.29M	3.45M	17.5M
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	2.78M	1.43M	1.56M	1.63M	1.83M
Total Liabilities	30.09M	538M	125M	46.81M	92.32M
Common Stock, Total	980K	2.11M	7.02M	7.38M	7.75M
Additional Paid In Capital	384M	505M	1.07B	1.6B	2.95B
Retained Earnings	-300M	-378M	-993M	-1.21B	-2.29B
Comprehensive Income and Other	-2.2M	-1.89M	-2.45M	-2.28M	-2.54M
Total Common Equity	83.28M	127M	77.69M	389M	659M
Total Equity	83.28M	127M	77.69M	389M	659M
Total Liabilities And Equity	113M	664M	203M	436M	751M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	98.12M	698M	702M	738M	775M
ECS Total Common Shares Outstanding	98.04M	211M	702M	738M	775M
Book Value / Share	0.85	0.6	0.11	0.53	0.85
Tangible Book Value	70.88M	125M	75.8M	387M	657M
Tangible Book Value Per Share	0.72	0.59	0.11	0.52	0.85
Total Debt	2.78M	519M	106M	7.22M	20.89M
Net Debt	-69.01M	170M	-80.14M	-405M	-693M
Debt Equivalent Oper. Leases	9.82M	12.42M	18.38M	28.07M	32.62M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	3.71M	1.39M	918K	1.05M	-
Full Time Employees	105	76	105	159	265
Part Time Employees	5	1	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-88.6M	-78.78M	-615M	-221M	-1.08B
Depreciation & Amortization - CF	1.44M	1.6M	2.05M	89K	146K
Amortization of Goodwill and Intangible Assets - (CF)	1.02M	914K	-	-	-
Depreciation & Amortization, Total	2.46M	2.51M	2.05M	89K	146K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-109K	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-1.92M	-2.58M	-7.01M
Asset Writedown & Restructuring Costs	-	8.47M	521M	15.01M	-
Stock-Based Compensation (CF)	12.8M	11.95M	14.11M	50.98M	732M
Other Operating Activities, Total	823K	5.65M	5.02M	229K	-320K
Change In Accounts Receivable	-1.14M	975K	359K	-	-
Change In Accounts Payable	-1.71M	-4.13M	2.26M	2.02M	15.3M
Change in Unearned Revenues	-813K	-7.28M	-	-	-
Change in Other Net Operating Assets	3.6M	19.05M	-4.99M	13.46M	16.11M
Cash from Operations	-72.59M	-41.58M	-76.76M	-142M	-323M
Capital Expenditure	-306K	-624K	-128K	-139K	-657K
Sale of Property, Plant, and Equipment	-	-	226K	-	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-475M	-15.01M	-
Investment in Marketable and Equity Securities, Total	-	-	-113M	-190M	-174M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-306K	-624K	-588M	-205M	-174M
Short Term Debt Issued, Total	110M	545M	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	110M	545M	-	-	-
Short Term Debt Repaid, Total	-110M	-25M	-	-	-
Long-Term Debt Repaid, Total	-	-	-24.69M	-100M	-
Total Debt Repaid	-110M	-25M	-24.69M	-100M	-
Issuance of Common Stock	78.09M	100M	112M	481M	618M
Other Financing Activities, Total	-172K	-155K	-619K	-	-
Cash from Financing	77.92M	620M	86.51M	381M	618M
Foreign Exchange Rate Adjustments	351K	-1.22M	839K	-18K	102K
Net Change in Cash	5.37M	577M	-577M	33.76M	120M
Supplemental Items
Cash Interest Paid	85K	434K	10.65M	8.81M	-
Cash Income Tax Paid (Refund)	7K	-	52K	-	-
Levered Free Cash Flow	-38.32M	-319M	-220M	-88.94M	84.08M
Unlevered Free Cash Flow	-38.15M	-317M	-210M	-83.51M	84.08M
Change In Net Working Capital	-768K	290M	-305M	-12.44M	-36.18M
Net Debt Issued / Repaid	0	520M	-24.69M	-100M	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-49.91	-10.43	-12.79	-41.31	-115.28
Return on Total Capital	-64.91	-11.09	-13.38	-45.49	-127.17
Return On Equity %	-108.89	-75.05	-601.85	-94.9	-206.1
Return on Common Equity	-108.89	-75.05	-601.85	-94.9	-206.1
Margin Analysis
Gross Profit Margin %	100	100	-	-	-
SG&A Margin	1.31K	3.79K	-	-	-
EBITDA Margin %	-4.69K	-9.02K	-	-	-
EBITA Margin %	-4.71K	-9.07K	-	-	-
EBIT Margin %	-4.76K	-9.2K	-	-	-
Income From Continuing Operations Margin %	-4.9K	-11.17K	-	-	-
Net Income Margin %	-4.9K	-11.17K	-	-	-
Net Avail. For Common Margin %	-4.9K	-11.17K	-	-	-
Normalized Net Income Margin	-3.06K	-6.35K	-	-	-
Levered Free Cash Flow Margin	-2.12K	-45.29K	-	-	-
Unlevered Free Cash Flow Margin	-2.11K	-44.9K	-	-	-
Asset Turnover
Asset Turnover	0.02	0	-	-	-
Fixed Assets Turnover	0.76	0.16	-	-	-
Receivables Turnover (Average Receivables)	1.53	0.78	-	-	-
Short Term Liquidity
Current Ratio	3.8	16.93	9.3	10.15	9.87
Quick Ratio	3.49	9.15	9.17	9.89	9.77
Operating Cash Flow to Current Liabilities	-2.83	-1.07	-3.76	-3.41	-4.42
Days Sales Outstanding (Average Receivables)	239	469.32	-	-	-
Long Term Solvency
Total Debt/Equity	3.34	409.59	136.56	1.86	3.17
Total Debt / Total Capital	3.23	80.38	57.73	1.82	3.07
LT Debt/Equity	2.03	392.65	132.95	0.89	2.66
Long-Term Debt / Total Capital	1.96	77.05	56.2	0.87	2.57
Total Liabilities / Total Assets	26.54	80.93	61.72	10.75	12.29
EBIT / Interest Expense	-306.71	-14.74	-5.39	-24.29	-
EBITDA / Interest Expense	-297.55	-14.1	-5.24	-23.88	-
(EBITDA - Capex) / Interest Expense	-298.64	-14.25	-5.25	-23.89	-
Total Debt / EBITDA	-0.03	-8.36	-1.23	-0.03	-0.02
Net Debt / EBITDA	0.83	-2.74	0.93	1.95	0.64
Total Debt / (EBITDA - Capex)	-0.03	-8.27	-1.23	-0.03	-0.02
Net Debt / (EBITDA - Capex)	0.82	-2.71	0.93	1.95	0.63
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	110.35	-61.03	-	-	-
Gross Profit, 1 Yr. Growth %	110.35	-61.03	-	-	-
EBITDA, 1 Yr. Growth %	67.07	-25.01	39.16	138.21	418.86
EBITA, 1 Yr. Growth %	66.72	-24.89	38.71	137.78	418.71
EBIT, 1 Yr. Growth %	64.68	-24.71	36.76	137.78	418.71
Earnings From Cont. Operations, 1 Yr. Growth %	68.13	-11.08	680.54	-64.01	387.81
Net Income, 1 Yr. Growth %	68.13	-11.08	680.54	-64.01	387.81
Normalized Net Income, 1 Yr. Growth %	70.22	-19.21	31.34	119.45	423.29
Diluted EPS Before Extra, 1 Yr. Growth %	26.39	-57.32	142.05	-68.76	365.76
Accounts Receivable, 1 Yr. Growth %	515.71	-76.16	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	172.4	45.84	19.33	22.02	192.98
Total Assets, 1 Yr. Growth %	10.61	485.82	-69.44	114.62	72.46
Tangible Book Value, 1 Yr. Growth %	7.54	76.16	-39.29	410.41	69.78
Common Equity, 1 Yr. Growth %	4.82	52.07	-38.66	400.37	69.48
Cash From Operations, 1 Yr. Growth %	50.87	-42.71	84.6	85.13	127.25
Capital Expenditures, 1 Yr. Growth %	-27.32	103.92	-79.49	8.59	372.66
Levered Free Cash Flow, 1 Yr. Growth %	33.12	733.65	-31.15	-59.88	-194.54
Unlevered Free Cash Flow, 1 Yr. Growth %	33.25	729.75	-33.8	-60.5	-200.68
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	49.39	-9.46	-	-	-
Gross Profit, 2 Yr. CAGR %	49.39	-9.46	-	-	-
EBITDA, 2 Yr. CAGR %	72.35	11.93	2.16	83.91	251.56
EBITA, 2 Yr. CAGR %	71.63	11.91	2.07	83.43	251.19
EBIT, 2 Yr. CAGR %	69.58	11.35	1.47	82.11	251.19
Earnings From Cont. Operations, 2 Yr. CAGR %	66.99	22.27	163.45	67.61	32.5
Net Income, 2 Yr. CAGR %	66.99	22.27	163.45	67.61	32.5
Normalized Net Income, 2 Yr. CAGR %	67.09	17.27	3.01	71.29	238.87
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.53	-26.55	1.64	-13.05	20.62
Accounts Receivable, 2 Yr. CAGR %	94.09	2.68	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	50.46	99.31	31.92	20.67	89.08
Total Assets, 2 Yr. CAGR %	8.53	154.55	33.79	-19.02	92.39
Tangible Book Value, 2 Yr. CAGR %	5.41	37.64	3.41	76.03	194.38
Common Equity, 2 Yr. CAGR %	2.76	26.26	-3.42	75.2	191.21
Cash From Operations, 2 Yr. CAGR %	79.04	-7.03	2.83	84.86	105.11
Capital Expenditures, 2 Yr. CAGR %	16.97	21.74	-35.32	-52.8	126.56
Levered Free Cash Flow, 2 Yr. CAGR %	-	233.02	139.58	-47.26	-38.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	232.51	134.37	-48.67	-36.93
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-4.54	-	-	-
Gross Profit, 3 Yr. CAGR %	-	-4.54	-	-	-
EBITDA, 3 Yr. CAGR %	-	30.6	20.36	35.47	159.86
EBITA, 3 Yr. CAGR %	-	30.31	20.21	35.31	159.39
EBIT, 3 Yr. CAGR %	-	29.37	19.24	34.77	158.14
Earnings From Cont. Operations, 3 Yr. CAGR %	-	35.35	126.82	35.68	139.3
Net Income, 3 Yr. CAGR %	-	35.35	126.82	35.68	139.3
Normalized Net Income, 3 Yr. CAGR %	-	31.14	21.78	32.54	148.55
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-24.98	9.3	-31.41	52.14
Accounts Receivable, 3 Yr. CAGR %	-	-13.59	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-	48.9	67.99	28.53	62.18
Total Assets, 3 Yr. CAGR %	-	90.38	25.57	56.62	4.19
Tangible Book Value, 3 Yr. CAGR %	-	25.09	4.77	76.07	73.92
Common Equity, 3 Yr. CAGR %	-	17.11	-0.74	67.12	73.27
Cash From Operations, 3 Yr. CAGR %	-	22.46	16.85	25.1	98.03
Capital Expenditures, 3 Yr. CAGR %	-	40.78	-32.76	-23.13	1.73
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	96.92	32.43	-35.93
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	94.16	29.85	-35.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-
Gross Profit, 5 Yr. CAGR %	-	-	-	-	-
EBITDA, 5 Yr. CAGR %	-	-	-	49.16	84.79
EBITA, 5 Yr. CAGR %	-	-	-	48.81	84.58
EBIT, 5 Yr. CAGR %	-	-	-	47.75	83.69
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	47.43	82.93
Net Income, 5 Yr. CAGR %	-	-	-	47.43	82.93
Normalized Net Income, 5 Yr. CAGR %	-	-	-	45.41	83.39
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-20.41	13.7
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	36.89	76.12
Total Assets, 5 Yr. CAGR %	-	-	-	35.25	48.94
Tangible Book Value, 5 Yr. CAGR %	-	-	-	43.41	58.38
Common Equity, 5 Yr. CAGR %	-	-	-	37.58	52.66
Cash From Operations, 5 Yr. CAGR %	-	-	-	44.39	46.34
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-9.07	9.31
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	23.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	24.04